KUBTEC is challenging the status quo of breast cancer surgery and is committed to reducing the excessive number of re-excision surgeries. Through continuous research and development of our proprietary 3D tomosynthesis technology, KUBTEC is empowering surgeons with immediate visualization of surgical margins in the operating theater, helping to reduce re-excision rates, preserve healthy breast tissue, and ultimately improve patient outcomes. At KUBTEC we understand that one of the most important drivers of a positive outcome for breast cancer patients is ensuring clear margins at the time of surgery. This is what drives us to push the boundaries and work to set a new standard of care. Our proprietary award-winning technologies, such as 3D breast specimen tomosynthesis; advanced, high-resolution specimen X-ray imaging; and intelligent workflow management features are allowing us to do just that for every surgeon, radiologist, pathologist, pathologists’ assistant, and patient. For further information, please review our product line at https://kubtec.com/